Publications
- COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus2020 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Treatment of relapsed chronic lymphocytic leukemia2019 | First Faculty of Medicine
- Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project2018 | Publication without faculty affiliation
- Idelalisib in the treatment of chronic lymphocytic leukaemia2015 | First Faculty of Medicine
- Chronic lymphocytic leukaemia2013 | First Faculty of Medicine
- ZAP-70 in B-cell chronic lymphocytic leukemia: clinical significance and methods of detection2006 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group2023 | Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia - cardiovascular complications and bleeding2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Other malignancies in the history of CLL: an international multicenter study coducted by ERIC, the European Research Initiative on CLL, in HARMONY2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...